Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:DGNOFOTCMKTS:PXXLFOTCMKTS:TGODFOTCMKTS:WECFY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGNOFDIAGNOS$0.15+3.1%$0.17$0.14▼$0.31$14.91M0.2562,220 shs5,500 shsPXXLFPoxel$0.25$0.25$0.25▼$0.25$7.24M0.53N/AN/ATGODFGreen Organic Dutchman$0.00$0.16▼$1.25$753K2.2760,349 shs4,354 shsWECFYWHITE ENERGY CO/S$0.22$0.22$0.22▼$0.29$21.84M2.52150 shsN/A20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGNOFDIAGNOS+3.10%+1.46%-15.33%-28.24%-39.50%PXXLFPoxel0.00%0.00%0.00%0.00%-64.29%TGODFGreen Organic Dutchman0.00%+900.00%+900.00%+900.00%-66.67%WECFYWHITE ENERGY CO/S0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGNOFDIAGNOSN/AN/AN/AN/AN/AN/AN/AN/APXXLFPoxelN/AN/AN/AN/AN/AN/AN/AN/ATGODFGreen Organic DutchmanN/AN/AN/AN/AN/AN/AN/AN/AWECFYWHITE ENERGY CO/SN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGNOFDIAGNOS 0.00N/AN/AN/APXXLFPoxel 0.00N/AN/AN/ATGODFGreen Organic Dutchman 0.00N/AN/AN/AWECFYWHITE ENERGY CO/S 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGNOFDIAGNOS$130K114.71N/AN/A($0.03) per share-4.88PXXLFPoxel$710K10.19N/AN/AN/A∞TGODFGreen Organic Dutchman$24.13M0.00N/AN/A$2.03 per share0.00WECFYWHITE ENERGY CO/S$1.38M15.82N/AN/A($0.39) per share-0.56Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGNOFDIAGNOS-$2.31M-$0.04N/A∞N/A-2,912.77%N/A-242.73%7/16/2025 (Estimated)PXXLFPoxel-$33.08MN/A0.00∞N/AN/AN/AN/AN/ATGODFGreen Organic Dutchman-$33.62M-$0.41N/AN/AN/A-83.86%-22.02%-14.58%N/AWECFYWHITE ENERGY CO/S-$7.13MN/A0.00∞N/AN/AN/AN/AN/ALatest PXXLF, WECFY, TGODF, and DGNOF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2025Q4 2025DGNOFDIAGNOS-$0.0070-$0.01-$0.0031-$0.01$0.09 million$0.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGNOFDIAGNOSN/AN/AN/AN/AN/APXXLFPoxelN/AN/AN/AN/AN/ATGODFGreen Organic DutchmanN/AN/AN/AN/AN/AWECFYWHITE ENERGY CO/SN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGNOFDIAGNOSN/A1.091.09PXXLFPoxelN/AN/AN/ATGODFGreen Organic Dutchman0.070.890.29WECFYWHITE ENERGY CO/SN/A0.370.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGNOFDIAGNOSN/APXXLFPoxelN/ATGODFGreen Organic Dutchman0.44%WECFYWHITE ENERGY CO/SN/AInsider OwnershipCompanyInsider OwnershipDGNOFDIAGNOSN/APXXLFPoxelN/ATGODFGreen Organic Dutchman8.70%WECFYWHITE ENERGY CO/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGNOFDIAGNOSN/A101.86 millionN/ANot OptionablePXXLFPoxel1528.95 millionN/ANot OptionableTGODFGreen Organic Dutchman4175.32 million68.77 millionNot OptionableWECFYWHITE ENERGY CO/SN/A99.26 millionN/ANot OptionablePXXLF, WECFY, TGODF, and DGNOF HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimePXXLF, WECFY, TGODF, and DGNOF Company DescriptionsDIAGNOS OTCMKTS:DGNOF$0.15 +0.00 (+3.10%) As of 06/16/2025 11:02 AM EasternDIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Poxel OTCMKTS:PXXLF$0.25 0.00 (0.00%) As of 06/16/2025Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.Green Organic Dutchman OTCMKTS:TGODFThe Green Organic Dutchman Holdings Ltd. engages in the production, cultivation, processing, and distribution of cannabis and related products. Its products include cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis. The company was founded by Scott Skinner and Jeannette VanderMarel in 2012 and is headquartered in Mississauga, Canada.WHITE ENERGY CO/S OTCMKTS:WECFY$0.22 0.00 (0.00%) As of 01/3/2020White Energy Company Limited engages in coal technology and exploration businesses in Australia, Indonesia, China, Singapore, South Africa, Mauritius, the United States, and the United Kingdom. The company holds license for the Binderless Coal Briquetting technology, which processes poor quality coal into a higher quality product. It also explores iron oxide-copper-gold-uranium styles of mineralization in tenements near Cooper Pedy, South Australia. White Energy Company Limited is headquartered in Brisbane, Australia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Digital: Now the High-Stakes Race to Build Begins Zscaler Upgraded: Wall Street Forecasts 26% More Upside Is CrowdStrike Stock Set to Break Out or Cool Off? New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 The Bottom Is in for Powerfleet: An Intelligent Time to Buy AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Why Nebius Group Is One of the Top AI Stocks to Watch Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
